Skip to main content

Glucose Health, Inc.

corporate_fare Company Profile

Glucose Health, Inc.

GLUC·OTC·Life Sciences·CIK 0001420108

Glucose Health, Inc. manufactures dietary supplements designed to help maintain healthy blood sugar, triglycerides, cholesterol, and digestive health. The company focuses on the consumer market segment of individuals concerned about pre-diabetes and/or Type-2 diabetes. Its principal product is Glucose Health®, which the company acquired in October 2014. Glucose Health, Inc. is in the early stages of manufacturing, marketing, and distributing this product. For the period ending December 31, 2016, the company generated a gross profit before operating expenses, a loss from operations, and a net loss per share. The company was incorporated under the laws of the State of Nevada on March 27, 2007, as Bio-Solutions Corp. On June 30, 2010, the board of directors approved an increase in authorized common stock from 75,000,000 to 90,000,000 shares and a 1.20 for 1 stock split. On October 17, 2012, an amendment was filed with the Nevada Secretary of State, increasing authorized capital from 90,000,000 shares of common stock to 200,000,000 shares of common stock, with a par value of $0.001. On January 10, 2014, the board of directors voted to reverse split the common stock on the basis of one share for each 10 shares outstanding, while maintaining the authorized capital structure at 200,000,000 shares.

Glucose Health, Inc. (OTC:GLUC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for GLUC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-18, rated 8/10.

Recent high-impact activity:

  • Glucose Health's GlucoDown Sales Surge Over 120% YOY, Retail Distribution Doubles

Financial Snapshot

Fiscal year ended December 31, 2016
Net Income
-$410.44K
Op. Cash Flow
-$39.26K
Gross Profit
$19.17K
Operating Income
-$86.65K
Cash & Equivalents
$20.54K
Debt / Equity
0.00×
Shares Outstanding
3.31M sh
Source: 10-K · filed 2017-03-28 · accession 0001477932-17-001354

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 314 shares in GLUC as of the October 30, 2026 settlement, a 75.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 17, 2026, 85.3% of GLUC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)314 shares as of October 30, 2026
Change vs prior period▼ 75.0%
Days to cover1.00 at avg daily volume of 27,998
Daily short volume (FINRA facilities)85.3% of 27,300 shares on November 17, 2026
5-day average short volume73.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.29 -3.33% today
52-week range · as of 2026-06-18 $0.02 – $0.6735
Market cap
$7.79M
Volume
21.5K (1.2× avg)
3-mo avg 18.3K
Live data · 2026-11-20 20:50 UTC · Market open

show_chartPrice Chart

Loading chart...

feed GLUC - Latest Insights

GLUC
Jun 18, 2026, 8:22 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.495
Real-time Price: $0.290 info
Change: -$0.205 (-41%) info
Market Cap: $7.794M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets